Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show ...
Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized to receive either ACOU085 or placebo administered prior to each cisplatin ...
The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...
By using a patient's DNA to craft personalized drug treatments, doctors can increase the efficacy and better the outcomes of ...
Major depressive disorder (MDD) is a widespread and serious mental health condition that affects how people think, feel, and ...
EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...
Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.
USA: A large international randomized clinical trial suggests that a personalized hemodynamic resuscitation approach ...
Fifteen leading university hospitals in Germany are participating in this interdisciplinary study. Patients are randomized to receive either ACOU085 or placebo administered prior to each cisplatin ...
Interim safety and efficacy data to be reported in Q1 VERO BEACH, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Processa ...
Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback